Surgical Procedure, Unspecified
Conditions
Keywords
Omentopexy, Complications, Metabolic surgery
Brief summary
Metabolic surgery has proven to be an effective treatment for obesity, with laparoscopic sleeve gastrectomy being the most popular procedure. Omentopexy (OP) is proposed as a strategy to reduce associated complications. Objective was to determine the effectiveness of omentopexy in controlling post-surgical symptoms and to measure the need for re-intervention, leakage, bleeding, and mortality in patients undergoing laparoscopic sleeve gastrectomy.
Detailed description
Patients who underwent laparoscopic sleeve gastrectomy (LSG). Of these patients, 53 received LSG with omentopexy (OP) and 52 underwent LSG without omentopexy (NO OP) between 2022 and 2023. Each group was attended by a different surgeon. The analysis focused on data concerning gastrointestinal symptoms recorded 24 hours postoperatively, as well as documented cases of bleeding, leakage, re-operation, and mortality during the hospitalization period
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosis of obesity * Adults over 18 years old * Undergoing sleeve gastrectomy * Consent to respond to the immediate postoperative symptom questionnaire
Exclusion criteria
* Repair of hiatal hernia * Refusal to complete the evaluation instrument * Unavailability of medical records
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative gastrointestinal symptoms | 24 hours | patients undergoing sleeve gastrectomy with omentopexy for obesity treatment will be lower compared to those undergoing sleeve gastrectomy without adjuncts. |
Countries
Mexico